-Key business priorities: examines the pharmaceutical companies’ important priorities for H1 (April–September) 2016 -Emerging and developed markets: provides information about key emerging and developed markets, which will offer most growth over H1 2016 -Change in M&A activity: analyzes pharmaceutical industry executives’ opinion on changes in merger and acquisition activity globally -Business concerns: identifies major business concerns that are likely to impact pharmaceutical companies -Change in capital expenditure: tracks the expected change in capital expenditure both globally and regionally -Purchase preferences: analyzing the purchasing behavior towards pharmaceutical equipment and investment allocations in the pharmaceutical equipment categories -Budget allocation: examining total procurement budget split between capital expenditure and operating expenditure, and tracking the changes in the budget for 2016 and expectations for 2017 -Equipment and drug categories: highlights the key equipment and drug categories with the highest revenue contribution to the pharmaceutical industry from 2016–2020
- Economic environment is more favorable in Eastern Europe and Australasia in H2 2016 as compared to H1 2016 - The majority of respondents communicated optimism about company and industry growth prospects for the next six months - Globally, supplier prices of ingredients are anticipated to increase by 2.5% over the next six months - Survey results indicate highest increase in spending on new product development in H2 2016 as compared to H1 2016 - Respondents with business operations in Asia-Pacific are more concerned about the performance of developing economies in H2 2016 as compared to H1 2016 - Organizations intend to focus on new product development and improving operational efficiency during the next six months Request a sample copy at http://www.reportsweb.com/inquiry&RW00020666/sample
Reason to Buy -Highlights key business priorities thus helping pharmaceutical companies to realign business strategy -Develop or adjust business expansion plans by using significant growth opportunities offered by key emerging and developed markets -Make changes in procurement budget allocations through procurement budget projections anticipated by executives for April–September 2016 -Helps to alter investment allocation by understanding key focus areas highlighted by survey respondents during H1 2016 -Enables organizations to make key decisions on purchase preferences and investments in pharmaceutical equipment
Introduction -Definitions -Methodology and sample size -Respondent profile Global Business Outlook in H1 2016 -Strategic business priorities -Emerging markets with significant growth potential -Growth potential for developed markets -Mergers and acquisition -Leading business concerns -Capital expenditure projections Procurement Budget, Expenditure Outlook, and High-yield Categories -Purchase preferences for pharmaceutical equipment -Average expenditure per purchase -Distribution of procurement budget between capital and operating expenditure -Change in procurement budget expenditure -Variation in pharmaceutical equipment budget from 2015–2016 to 2016–2017 -Highest revenue contributing regions for pharmaceutical equipment’s market, 2016–2020 -Leading drug categories, 2016–2020 -Top most pharmaceutical equipment types, 2016–2020 Appendix